Unknown

Dataset Information

0

Piperine Induces Hepatic Low-Density Lipoprotein Receptor Expression through Proteolytic Activation of Sterol Regulatory Element-Binding Proteins.


ABSTRACT: Elevated plasma low-density lipoprotein (LDL) cholesterol is considered as a risk factor for atherosclerosis. Because the hepatic LDL receptor (LDLR) uptakes plasma lipoproteins and lowers plasma LDL cholesterol, the activation of LDLR is a promising drug target for atherosclerosis. In the present study, we identified the naturally occurring alkaloid piperine, as an inducer of LDLR gene expression by screening the effectors of human LDLR promoter. The treatment of HepG2 cells with piperine increased LDLR expression at mRNA and protein levels and stimulated LDL uptake. Subsequent luciferase reporter gene assays revealed that the mutation of sterol regulatory element-binding protein (SREBP)-binding element abolished the piperine-mediated induction of LDLR promoter activity. Further, piperine treatments increased mRNA levels of several SREBP targets and mature forms of SREBPs. However, the piperine-mediated induction of the mature forms of SREBPs was not observed in SRD-15 cells, which lack insulin-induced gene-1 (Insig-1) and Insig-2. Finally, the knockdown of SREBPs completely abolished the piperine-meditated induction of LDLR gene expression in HepG2 cells, indicating that piperine stimulates the proteolytic activation of SREBP and subsequent induction of LDLR expression and activity.

SUBMITTER: Ochiai A 

PROVIDER: S-EPMC4592265 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Piperine Induces Hepatic Low-Density Lipoprotein Receptor Expression through Proteolytic Activation of Sterol Regulatory Element-Binding Proteins.

Ochiai Ayasa A   Miyata Shingo S   Shimizu Makoto M   Inoue Jun J   Sato Ryuichiro R  

PloS one 20151002 10


Elevated plasma low-density lipoprotein (LDL) cholesterol is considered as a risk factor for atherosclerosis. Because the hepatic LDL receptor (LDLR) uptakes plasma lipoproteins and lowers plasma LDL cholesterol, the activation of LDLR is a promising drug target for atherosclerosis. In the present study, we identified the naturally occurring alkaloid piperine, as an inducer of LDLR gene expression by screening the effectors of human LDLR promoter. The treatment of HepG2 cells with piperine incre  ...[more]

Similar Datasets

| S-EPMC23450 | biostudies-literature
| S-EPMC5415137 | biostudies-literature
| S-EPMC1201629 | biostudies-literature
| S-EPMC2882723 | biostudies-literature
| S-EPMC5416757 | biostudies-literature
| S-EPMC3258893 | biostudies-other
| S-EPMC6857156 | biostudies-literature
| S-EPMC3136361 | biostudies-literature
| S-EPMC5104945 | biostudies-literature
| S-EPMC2725716 | biostudies-literature